December 2018, Self-screen and Novosanis received a prestigious Eurostar grant

February 2019, Results from an international study confirm the robustness of the QIAsure Methylation Test

November 2018, QIAGEN launches Self-screens HPV-Risk Assay as the QIAscreen HPV PCR Test

September 2018, Self-screen successfully passed the transition to the ISO13485:2016 standard

July 2018, Focal trial shows significantly lower CIN3+ incidence for women primary screened for HPV compared to cytology

May 2018, United States Patent and Trademark Office grants patent of methylation markers PRDM14 and FAM19A4 to Self-screen B.V.